Live: Can CrowdStrike Deliver Another Blowout Quarter With Q1 Earnings Tonight?

Investing

MannKind : MNKD

All MannKind Articles

305 Articles

Jon C. Ogg | May 14, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Akamai, Avago, MannKind, Pandora, Randgold and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, May 14, 2014. They include Akamai Technologies,…

Jon C. Ogg | Apr 23, 2014 at 10:50 AM EDT

Companies Betting on the Next 10 Blockbuster Drugs

24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in…

Jon C. Ogg | Apr 7, 2014 at 11:00 AM EDT

FDA Keeps Driving Up Future Cost of Inhalable Insulin

While the FDA has been far from a friend to MannKind over the past few years, the latest FDA panel…

Paul Ausick | Apr 2, 2014 at 4:01 PM EDT

The 4 Stocks That Rescued the Rally for One More Day

thinkstockApril 2, 2014: Markets opened mixed on Wednesday following in the ADP payroll data and n increase in factory orders…

Jon C. Ogg | Apr 2, 2014 at 7:30 AM EDT

Can MannKind Shares Double Again on FDA Approval? (Final)

MannKind has a serious victory within its grasp. The company has struggled to get its Afrezza inhalable insulin to market…

Jon C. Ogg | Apr 1, 2014 at 6:06 PM EDT

Vindication for MannKind With FDA Panel Backing

ThinkstockMannKind Corp. (NASDAQ: MNKD)had been trading as though the stock was bracing for an U.S. Food and Drug Administration (FDA)…

Jon C. Ogg | Mar 31, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: BlackBerry, ING, Lululemon, MannKind, Vipshop and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on the final day of…

Jon C. Ogg | Jan 10, 2014 at 2:36 PM EST

Volatility and Options in MannKind Shaking Speculators Out

ThinkstockMannKind Corp. (NASDAQ: MNKD) is a stock that has been on a wild ride for many years. The company’s inhalable…

Jon C. Ogg | Jan 10, 2014 at 9:05 AM EST

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look…

Jon C. Ogg | Oct 14, 2013 at 2:36 PM EDT

Is Inhalable Insulin Assured To Be Approved By The FDA?

ThinkstockIf you have followed the diabetes drug market for very long, chances are high that you have run across the…

Jon C. Ogg | Sep 6, 2013 at 8:40 AM EDT

Top Analyst Downgrades and Stocks to Sell: Buckeye, MannKind, VistaPrint and More

Jon OggInterest rates have risen and volatility in stocks has resumed. Traders and investors are looking for bargain stocks but…

Paul Ausick | Aug 16, 2013 at 4:06 PM EDT

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the…

Jon C. Ogg | Jun 7, 2013 at 8:35 AM EDT

Top Analyst Downgrades and Stocks to Sell: Bank of America, J.P. Morgan, Intel, Sprint, More

These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Friday, June 7,…

Paul Ausick | May 24, 2013 at 4:07 PM EDT

Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out

U.S. equity markets opened sharply lower again this morning, but this time reacting to yesterday’s comments by Fed Chairman Ben…

Paul Ausick | May 23, 2013 at 4:05 PM EDT

Closing Bell for Thursday on Wall Street: Markets Stall on Japan Losses

U.S. equity markets opened sharply lower this morning, taking a lead from Japan’s Nikkei, which fell more than 7% for…

1 … 16 17 18 19 20 21

MannKind : MNKD

All MannKind Articles

Top Analyst Upgrades and Downgrades: Akamai, Avago, MannKind, Pandora, Randgold and More

Companies Betting on the Next 10 Blockbuster Drugs

FDA Keeps Driving Up Future Cost of Inhalable Insulin

The 4 Stocks That Rescued the Rally for One More Day

Can MannKind Shares Double Again on FDA Approval? (Final)

Vindication for MannKind With FDA Panel Backing

Top Analyst Upgrades and Downgrades: BlackBerry, ING, Lululemon, MannKind, Vipshop and More

Volatility and Options in MannKind Shaking Speculators Out

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

Is Inhalable Insulin Assured To Be Approved By The FDA?

Top Analyst Downgrades and Stocks to Sell: Buckeye, MannKind, VistaPrint and More

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Top Analyst Downgrades and Stocks to Sell: Bank of America, J.P. Morgan, Intel, Sprint, More

Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out

Closing Bell for Thursday on Wall Street: Markets Stall on Japan Losses

Live: Can CrowdStrike Deliver Another Blowout Quarter With Q1 Earnings Tonight?

Live: Will Broadcom Crush Q2 Earnings Tonight After Market Close?

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

MannKind : MNKD

All MannKind Articles

Top Analyst Upgrades and Downgrades: Akamai, Avago, MannKind, Pandora, Randgold and More

Companies Betting on the Next 10 Blockbuster Drugs

FDA Keeps Driving Up Future Cost of Inhalable Insulin

The 4 Stocks That Rescued the Rally for One More Day

Can MannKind Shares Double Again on FDA Approval? (Final)

Vindication for MannKind With FDA Panel Backing

Top Analyst Upgrades and Downgrades: BlackBerry, ING, Lululemon, MannKind, Vipshop and More

Volatility and Options in MannKind Shaking Speculators Out

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

Is Inhalable Insulin Assured To Be Approved By The FDA?

Top Analyst Downgrades and Stocks to Sell: Buckeye, MannKind, VistaPrint and More

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Top Analyst Downgrades and Stocks to Sell: Bank of America, J.P. Morgan, Intel, Sprint, More

Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out

Closing Bell for Thursday on Wall Street: Markets Stall on Japan Losses

Live: Can CrowdStrike Deliver Another Blowout Quarter With Q1 Earnings Tonight?

Live: Will Broadcom Crush Q2 Earnings Tonight After Market Close?

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later